Definium Therapeutics
DFTXNasdaq United StatesHealth CareMedicinal Chemicals and Botanical Products
Market cap
$4.088 B
$30.43 -6.96%
Close of 6 Nov 2026
As of 6 Nov 2026, Definium Therapeutics (DFTX) has a market capitalization of $4.09B. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.
Revenue
—
Not reported
Earnings
-$183.8M
Loss-making
Shares outstanding
134,366,950
Latest filing cover page
P/E ratio
—
Cap ÷ net income
Medicinal Chemicals and Botanical Products, ranked by market cap
All 26 →- #2British American Tobacco p.l.c.BTI$136.4B
- #3Altria GroupMO$129.3B
- #4Definium TherapeuticsDFTX$4.09B
- #5Regencell BioscienceRGC$2.61B
- #6Trulieve CannabisTRLV$2.11B
What if Definium Therapeutics were worth as much as…
Open the what-if tool →Where these numbers come from
Share counts and financials for Definium Therapeutics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.